We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Could a 50 Year Old Sample of Cat Brain Tissue Challenge Current Methylmercury Wisdom?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Specialties > Could a 50 Year Old Sample of Cat Brain Tissue Challenge Current Methylmercury Wisdom?
Specialties

Could a 50 Year Old Sample of Cat Brain Tissue Challenge Current Methylmercury Wisdom?

Sean Mallon
Sean Mallon
Share
5 Min Read
SHARE

In 1956, doctors at the Chisso Corporation factory hospital in Minamata, Kumamoto, Japan, received a 5 year old patient with puzzling symptoms; the young girl exhibited convulsions as well as difficulty walking and speaking. When her sister arrived at the hospital with the same symptoms – and the girls’ mother mentioned that neighbors had been experiencing the same for some time, doctors launched a larger investigation. What they found was not only troubling, but led to the uncovering of one of the largest mass poisonings of all time.

First thought to be a contagious disease, what came to be known as Minamata Disease caused a neurological syndrome that led to muscle weakness, vision problems, hearing and speech damage, paralysis, coma, insanity, and even death. Caused by the Chisso Corporation’s release of mercury and other industrial chemical byproducts in waterways, Minamata Disease made its way into the local human and animal populations as each ingested shellfish and fish from Minamata Bay. These fish bioaccumulated the mercury and resulted in toxic mercury levels of many area residents. Officially, the poisoning affected 2,265 human victims before 1968 and killed 1,784; however, congenital mercury poisoning continues to affect the area, and cat, dog, and human deaths occurred for over 30 years.

Isolating the Source

In 1968 – and through the 1990s – scientists argued that Minamata Disease was caused by the Chisso Corporation producing methylmercury and pouring it into Minamata Bay. Studies performed since agreed, noting that methylmercury had been found in sludge from the bay, shellfish samples, and even umbilical cords from babies born at the time. In addition, a Minamata doctor fed wastewater to two cats, noting that their behavior and the resulting brain lesions he observed after autopsy were consistent with methylmercury poisoning.

Now, however, advances in the technology scientists use to study the molecular fingerprints certain substances leave on the brain have helped researchers challenge that assertion. If the hypothesis proves correct, then advances in toxicity screening using single cell analysis via a 96 well plate dispenser will likely produce new information about how an alternative, organic mercury compound acts upon mammal neurological systems.

New Research

Researchers at the Stanford Synchrotron Radiation Lightsource have employed a technique that involves exposing the existing brain tissue samples from one of the original cats to extensive x-ray radiation and analyzing the resulting light spectrum. They’ve found that most of the molecules within the cat’s brain consist of alpha-mercuri-acetaldehyde, an organic compound that likely originated in the wastewater from Minamata Bay. This finding and its interpretation that the poisonings may have been caused by this compound directly opposes the longstanding views that Minamata Disease is caused by methylmercury.

Methylmercury as a toxic compound has been under scrutiny since the 1980s, when teams of researchers began to evaluate how methylmercury bioaccumulated in seafood could harm humans who eat shellfish and fish. During that time, the Environmental Protection Agency took a safe approach and set an extremely low threshold for the presence of methylmercury in seafood. Some researchers fear that the new Minamata cat study could be used to relax these thresholds. 

The Future of Methylmercury and Toxicity Research

Even as the Stanford team continues its research into alpha-mercuri-acetaldehyde, procuring human samples in hopes of discovering whether or not the compound is present in other species as a result of the Minamata disaster, other researchers point to recent proof of methylmercury toxicity. They cite a 2015 study, among others, that proves mammalian neural cell cytotoxic effects of methylmercury, and insist that EPA standards restricting methylmercury should not be lifted. In fact, these researchers cite a subsequent 1971 industrial poisoning incident in Iraq involving methylmercury – proof that no matter the compounds present in the Minamata incident, methylmercury is extremely dangerous.

While questions regarding the source of Minamata Disease may have been raised by this new finding, more information is needed. As a result, toxicity research regarding both alpha-mercuri-acetaldehyde and methylmercury using mammalian cell lines will likely continue. What’s clear is that scientists on both sides of the debate endeavor to prevent horrific poisoning events like the Minamata disaster from ever occurring again.

More Read

The “Luck of the Jewish” in Cancer
The Role of Genetics in Vision Disorders: A Deeper Look
How Cancer Patients Can Fund Their Treatment
What is the Future of Social Media for Orthopedic Surgeons?
Seven Common Plastic Surgery Complications People Tend To Ignore
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Workers Comp Claim Denied – Now What?  -- AI-generated illustration
Workers Comp Claim Denied – Now What? 
Policy & Law
October 9, 2026
The Case for Proactive Nutrient Support and Where IV Therapy Fits In -- AI-generated illustration
The Case for Proactive Nutrient Support and Where IV Therapy Fits In
Health Therapies
October 5, 2026
Biofeedback Technology in Addiction Treatment: What the Evidence Shows So Far -- AI-generated illustration
Biofeedback Technology in Addiction Treatment: What the Evidence Shows So Far
Addiction Addiction Recovery
September 28, 2026
Charity Care Is Written Into Hospital Policy. It Rarely Makes It Onto the Bill. -- AI-generated illustration
Charity Care Is Written Into Hospital Policy. It Rarely Makes It Onto the Bill.
Business Hospital Administration
September 25, 2026

You Might also Like

In Praise of FDA Collaboration: The Cardiac Safety Example

December 18, 2014
keratosis pilaris
SkinSpecialties

How To Deal With Keratosis Pilaris?

October 27, 2024
Specialties

How Does Occupational Therapy Help Kids with Autism?

June 2, 2018

October is Breast Cancer Awareness Month

September 30, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?